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Abstract
Biological function arises from the interplay of proteins, transcripts, and metabolites. An ongoing 
revolution in miniaturization technologies has created tools to analyze any one of these species in 
single cells, thus resolving the heterogeneity of tissues previously invisible to bulk measurements. 
An emerging frontier is single cell multi-omics, which is the measurement of multiple classes of 
analytes from single cells. Here, we combine bead-based transcriptomics with microchip-based 
proteomics to measure intracellular proteins and transcripts from single cells and defined small 
numbers of cells. The transcripts and proteins are independently measured by sequencing and 
fluorescent immunoassays respectively, to preserve their optimal measurement modes, and linked 
by encoding the physical address locations of the cells into digital sequencing space using 
spatially patterned DNA barcodes. We resolve cell-type-specific protein and transcript signatures 
and present a path forward to scaling the platform to high-throughput.
Introduction
The advent of quantitative, high throughput single cell ‘omics’ technologies is transforming 
our understanding of biology by resolving the heterogeneity of tissues, from development1 
to function2 to disease3. Single cell ‘whole’ transcriptomics methods, which combine next 
generation sequencing tools, microfluidic chips, and molecular barcoding4–7, have defined 
the paradigm with affordable benchtop implementations. Single cell proteomics methods 
provide excellent specificity including post-translational modification detection8–11, but 
remain reliant on antibodies12, which places practical limits on multiplexing. Further, 
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different classes of proteins, from secreted to membrane-bound to cytoplasmic, can require 
different analysis platforms. An outstanding challenge is to combine single cell proteomic 
assays with transcriptomics to quantify both the direct protein effectors of cell function and 
the broader mRNA regulatory framework.
Proteins and transcripts are typically assayed for quantification using orthogonal signals 
(fluorescence and sequence reads). The transduction and amplification modes of these 
signals are generally incompatible for simultaneous assays, especially at the single cell level, 
but new solutions have emerged that coerce one signal into the other13–16. For example, 
groups have effectively “sequenced” surface proteins by tagging antibodies with DNA 
barcodes17–19 and analyzing both surface proteins and transcripts via sequencing. Splitting 
the contents of a single cell20–22 provides an alternative, albeit technically challenging 
method also capable of multi-omic analysis. New techniques in advanced molecular 
barcoding23, amplification, and expansion microscopy24 may soon allow proteins and 
mRNA to be simultaneously imaged in fixed single cells and tissues.
Here we report on a single cell method for simultaneous measurement of a panel of 
functional intracellular proteins plus whole transcriptome sequencing. The approach 
combines the single cell barcode chip (SCBC) platform for proteomics8, 9, 11 with bead-
based droplet transcriptomics (Fig. 1)4, 6. In an SCBC, single cells are isolated within 
individual microchambers. After cell lysis, a panel of target proteins, whether secreted, 
cytoplasmic, or membrane-bound, is specifically captured using an antibody array and read 
out using a non-amplified fluorescent sandwich immunoassay. For transcriptomics, we add 
sequencing beads to the chambers and encode the physical microchamber location on to the 
beads with short DNA oligomers. After capturing transcripts from the lysed cell, the beads 
are pooled for sequencing and the DNA-encoded location of individual cell transcriptomes 
can be traced back to specific microchambers and the associated protein readouts.
Experimental
SCBC Mold and Device Fabrication
The SCBC is created in two steps. The first step involves construction and assembly of the 
molds and integrated microfluidic device used for executing the multi-omic SCBC 
experiments. The second step involves the flow patterning of the DNA barcodes that are 
used for assembling the DEAL arrays onto glass slides, and the flow patterning to encode 
the X-location of the cell microchambers.
Microfluidic Molds and Device Assembly.
Materials needed:  Sylgard 184 PDMS (Ellsworth Adhesives, Germantown WI), SU-8 
2025, SU-8 Developer, SPR220–7.0, CD26 Developer (Microchem, Seattle WA), 0.5 mm 
hole punch, scotch tape.
The two-layer SCBC device for single cell isolation, proteomics, and transcriptomics (Fig. 
1a) was fabricated as previously described9 with some modifications. Molds were 
photolithographically defined using SPR 220–7.0 for the flow layer (Fig. S1a) and SU-8 for 
the control layer (Fig. S1b, File S1). The channel height of the control layer was 40 microns 
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and the channel height for the flow layer was 14 microns. Channel widths for the flow layer 
ranged from 100 to 400 microns wide.
The control layer was made with degassed PDMS (Sylgard 184) mixed at a ratio of 1 unit 
crosslinker to 8 units elastomer (1:8). The flow layer had two functional halves: the cell 
chambers and the microfluidic filter. For the cell chambers, softer PDMS was needed to 
allow valves to open and close easily. The microfluidic filter required stiffer PDMS to 
prevent the filter from collapsing or becoming blocked. To create the two different halves of 
the flow layer, softer 1:20 PDMS was poured over the half of the wafer mold with cell 
chambers and stiffer 1:8 PDMS was poured over the other half containing the filter (Fig. 
S1a). The wafer was placed on a spin coater and spun for 1 minute at 2000 RPM to create a 
PDMS flow layer with a height of 100 microns. Spin coating prevented the softer PDMS 
used for the cell chambers from mixing with the stiffer PDMS of the filter and vice versa to 
maintain separation between the two halves of the wafer mold. The height difference 
between the spin-coated softer and stiffer PDMS halves was negligible. The flow layer was 
cured for 15 minutes at 80 °C after spinning, and the control layer (~ 0.5 cm tall) was 
attached to the top of the flow layer.
The two-layer device was cured for 2 hours at 80 °C and lifted from the wafer, and access 
holes were punched into the device. In the flow layer (Fig. S1a, c), holes punched included 
the cell and bead inlet (1) and outlet, the reagent and wash inlet (2) and outlet (9), the 
individual row lysis buffer inlets (3–8) and outlets, and the transcriptomic inlet (10) and 
outlet. In the control layer (Fig. S1b, c), separate holes were required for valves regulating 
the inlets and outlets of the flow layer (1–4, 7–10, 12), as well as a cell chamber valve 
separating adjacent chambers (5), a lysis valve separating lysis buffer chambers from cell 
chambers (6), and a separation valve to isolate the cell chamber side of the chip from the 
microfluidic filter side (11). After the holes were punched they were flushed with water, the 
surfaces of the PDMS device were cleaned with scotch tape to enhance adhesion and remove 
particles, and the two-layer SCBC device was completed and ready for attachment to the 
glass slide.
Flow Patterning for DNA Barcode and X-Coordinate Oligo Addition.
Materials needed:  SuperChip polylysine-coated glass slides (Thermo Scientific, Federal 
Way WA), 0.1% (w/v) polylysine solution (Sigma, St. Louis MO), DNA oligomers (Table 
S1), BS3 crosslinker (Thermo Scientific 21580).
Every microchamber was surface-patterned with a DNA barcode which served two 
purposes. All barcode stripes except one were patterned with single-stranded (ss)DNA, and 
used for the spatially-selective assembly of DNA-labeled capture antibodies (the DEAL 
method)25. The remaining stripe was patterned with double-stranded (ds)DNA encoding the 
X-coordinate of the microchamber (Fig. S1d). Glass slides used for DNA-encoded antibody 
library (DEAL) arrays were prepared by flow patterning 20-micron wide DNA barcode lines 
as previously described9. A PDMS flow pattern with a winding snake-like pattern of parallel 
channels (File S1) was adhered to a SuperChip polylysine coated glass slide and cured for 2 
hours at 80 °C. Polylysine solution was passed through the channels overnight, and amine-
functionalized ssDNA oligomers (B-, C-, D-, I-, P-DNA, Table S1) were activated with BS3 
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crosslinker and flowed through the channel for 1 hour over ice. The device was removed 
from ice and incubated for 2 hours at room temperature to complete glass surface 
functionalization. The flow pattern was removed and the glass slide was washed in 
PBS-0.05% tween (PBST) and water.
A second flow patterning step was used to pattern X-coordinate ssDNA (X-Location 
Column 1–6, Table S1) on to the DNA barcode (P-DNA, Table S1). The second flow pattern 
consisted of individually addressable vertical channels (Fig. S1d, File S1). X-coordinate 
ssDNA was added to a solution of 0.5% BSA and 1mM MgCl2 in phosphate buffered saline 
(PBS) at a concentration of 10 nM and flowed through the second flow pattern, along with a 
Cy3 labeled DNA reporter to visually affirm that flow pattern molds were correctly aligned 
(I’-DNA, Table S1). The resulting base-paired X-coordinate dsDNA had 12 complementary 
base pairs with the DNA barcode (P-DNA), rendering it stable at room temperature (Fig. 1b, 
Tm = 38 °C). The channels were washed with PBST and the flow pattern was detached, 
creating a glass slide with a pattern of 3 ssDNA barcode lines and two dsDNA barcode lines, 
one containing the Cy3 fluorophore for visualization and one containing the X-coordinate 
dsDNA. The two-layer PDMS devices were aligned to the glass slide and cured at 80 °C for 
2 hours to complete the multi-omic SCBC.
Multi-Omic SCBC Operation
The multi-omic SCBC is first primed and loaded on the day of measurements, and then split 
into three processing sections: cell lysis, proteomics, and transcriptomics. The multi-omic 
SCBC approach is illustrated in Fig. 1b–d. The completed SCBC contains an array of 
microchambers, each split into a cell chamber and lysis chamber and denoted by an X and Y 
DNA barcode (Fig. 1b–d, Fig. S1a–c). Cells and sequencing beads (10 μm diameter) are 
loaded into the cell chambers, and lysis buffer with two added ssDNA oligos, one variable 
and one constant, is loaded into the lysis chambers (Fig. 1b, Fig. S2a). The constant ssDNA 
is a displacement strand to displace one strand of the X-coordinate dsDNA from the barcode 
stripe, while the variable ssDNA is specific to each row of microchambers and encodes the 
Y-coordinates.
Finally, a computation pipeline analyzes proteomics and transcriptomics data separately 
before correlating the single-cell measurements. Full details of multi-omic SCBC operation 
are found in Table S3.
SCBC Chip Priming and Reagent Preparation.
Materials needed:  DNA oligomers (Table S1), antibodies (Table S2), Zeba 7K MWCO 
spin desalting columns (Thermo Scientific 89882), S-HyNic, S-4FB antibody-oligo 
crosslinkers (Trilink, San Diego CA), Amicon Ultra-4 centrifugal filter units (Millipore 
UFC801008, Burlington MA), diamond scribe.
To prepare the SCBC chip, the following reagents were prepared beforehand. Capture 
antibodies and DNA were purified and desalted with Zeba spin columns, conjugated to DNA 
(B’-, C’-, D’-DNA, Table S1) using the manufacturer’s protocols9 with S-HyNic and S-4FB, 
purified with FPLC (Superdex 200) and concentrated with Amicon Ultra-4 centrifugal filter 
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units. The sequencing beads contained the same oligos as those reported previously4, but 
were custom manufactured using 10 micron diameter beads. Each oligo has a primer region, 
a bead identifier region unique to each bead, a random unique molecular identifier (UMI) for 
single molecule tracking and PCR bias correction, and a polyT tail for capturing 
polyadenylated transcripts (bead oligo, Table S1).
On the day of operation (Fig. S2a), the bottom of the glass device was first scored between 
the filter and the microchambers using a diamond scribe to facilitate later cleavage of the 
device without disturbing the valve connections. The valve attachments were then filled with 
water and the channels of the device were filled with 3% BSA in PBS. The valves were 
pressurized to allow water to fill the control layer channels and the device was incubated for 
1 hour for blocking. After blocking, the microchambers were filled with a 1:20 dilution of 
the antibodies in a 1.5% BSA in PBS solution for 1 hour at 37 °C to allow complementary 
strands (e.g. Glass-B-DNA, Antibody-B’-DNA) to base pair to convert the ssDNA barcodes 
into DEAL antibody barcodes. Following antibody loading, one final blocking step of 1.5% 
BSA in PBST was done for 1 hour at room temperature, following by a wash of 100 µL 
PBST through the device.
Cell Loading and Lysis, and Bead Location Encoding and Collection.
Materials needed:  DNA oligomers (Table S1), sequencing beads (Chemgenes, Wilmington 
MA), cells, RNAse inhibitor (Lucigen 30281, Radnor PA), 6X saline sodium citrate (SSC, 
Ambion, Foster City CA).
Lysis buffer: 18 µL cell lysis buffer (Cell Signaling #9803, Danvers MA), 2 µL protease-
phosphatase inhibitor (Cell Signaling #5872), 10 µL 20% Ficoll PM-400 (GE Health Care 
17030010, Pittsburgh PA), 2µL RNAse inhibitor, 2 µL 2M DTT, 30 µL water, 6 µL 10 nM 
Cy3 labeled displacement DNA (P’-Displacement DNA, TableS 1).
A separate solution of lysis buffer was prepared for each row of the device. The lysis valve 
was closed to prevent any possible leakage of lysis buffer in to the cell chambers (Fig. S1b, 
valve 6). For each row, 1 µL of a 100 pM solution of the appropriate Y-coordinate ssDNA 
(Y-Location Row 1–6, Table S1) was added to 10 µL of lysis buffer and flowed through each 
row of lysis chambers before cell loading.
HEK and U87MG cells were cultured in Dulbecco’s Modified Eagle Medium supplemented 
with 10% fetal bovine serum and 1% penicillin-streptomycin. After trypsinization, cells 
were washed twice with PBS and suspended in 0.01% BSA in PBS. A solution of 1 million 
cells and 4 million beads per mL was prepared, 1 µL of RNAse inhibitor was added to 20 µL 
of the cell/bead mixture, and the mixture was flowed through the device. When the 
appropriate cell loading was achieved, the cell chamber valve was closed to isolate the 
microchambers (Fig. S1b, valve 5) and the device was optically inspected by microscope to 
record the numbers of cells and beads in each chamber (Fig. 1e, Fig. 2a, Fig. S3a).
Cells were lysed by opening the lysis valve and allowing diffusion to mix the contents of the 
lysis and cell chambers, triggering 4 capture events (Fig. 1c). (1) Selected proteins are 
captured on the DEAL array. (2) Transcripts are captured on the sequencing beads. (3) One 
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ssDNA oligo hybridizes to the sequencing beads, encoding the Y-coordinate of the cell 
chamber onto the beads. (4) A second ssDNA displaces the complementary strand of the 
dsDNA on the X-coordinate barcode stripe. The released strand is captured on the 
sequencing bead, thus encoding the X-coordinate of the bead (Fig. 1d). The displacement 
DNA in the lysis buffer was able to displace X-coordinate ssDNA from the chip during cell 
lysis due to the 21 base pair complementary region between P’-Displacement DNA and P-
DNA, compared to just 12 between X-coordinate ssDNA and P-DNA. Cells were lysed on 
ice for 15 minutes with the valves open, followed by 15 minutes on ice with the valves 
closed and finally 2 hours at room temperature on a shaker to maximize analyte capture.
Following lysis and capture of proteins, transcripts, and X-Y coordinate ssDNA, the device 
was preconditioned by filling the upstream flow channels with SSC, the cell chamber 
isolation valve was opened, and sequencing beads were washed with SSC and collected at 
the filter (Fig. S2b). The filter contains 5 micron wide slits to allow solutions to pass through 
while retaining beads (Fig. S2c). After collection, the valve separating the two halves of the 
chip was closed and the chip was cleaved, first by carving a wedge of PDMS out of the 
device, then placing the SCBC on a foam piece and applying pressure to both sides to 
prevent delamination of the PDMS device from the glass beneath. With enough pressure, the 
chip was cleaved along the scored line with each side of the PDMS two-layer device 
remaining bound to the glass on both sides of the chip.
Proteomics Analysis.
Materials needed:  Antibodies (Table S2).
For the proteomics side of the chip, the device remained at room temperature. The entire 
half of the chip containing the cell chambers was protected from light for antibody 
development, incubated with a 1:20 dilution of detection antibodies in a solution of 1.5% 
BSA in PBS for 60 minutes, and washed with PBST for 30 minutes (Fig. S2b). The chip was 
imaged in the Genepix 4400 machine with laser power settings of 600 gain and 80% power 
for the 635 nm wavelength laser and 450 gain and 15% power for the 532 nm wavelength 
laser. The chip had two fluorescent alignment markers available, one added during X-
coordinate ssDNA loading which spanned the entire chip, and another in the P’-
Displacement DNA added during lysis. Each barcode strip was measured using three 
circular regions and mean values were used. Background values were calculated by the 
average of protein signals from chambers with zero cells for multi-dimensional analysis.
Transcriptomics Analysis.
Materials needed:  DNA oligomers (Table S1), Ampure XP beads (Beckman, Beverly 
MA), Nextera XT kit, MiSeq sequencing kit (Illumina, San Diego CA)
Reverse transcriptase solution: 2 µL Maxima H- reverse transcriptase, 10 µL reverse 
transcriptase buffer (Thermo Fisher, Waltham MA), 5 µL dNTP mix (Takara 4030, Mountain 
View CA), 10 µL 20% Ficoll PM-400, 1 µL RNAse inhibitor, 2 µL 0.1 mM template switch 
oligo solution (Table S1), 20 µL water.
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TE-SDS solution: 10 mM Tris pH 8.0, 1 mM ethylene diaminotetraacetic acid (EDTA), 
0.5 % sodium dodecyl sulfate (SDS).
TE-TW solution: 10 mM Tris pH 8.0, 1 mM EDTA, 0.01% Tween-20.
Exonuclease solution: 2.5 µL Exonuclease enzyme, 5 µL Exonuclease buffer (NEB M2093, 
Ipswich MA), 42.5 µL water.
PCR solution: 100 µL water, 100 µL KAPA HiFi Hotstart Readymix (Sigma Aldrich, St. 
Louis MO), 10 µL 10 µM SMART primer, 5 µL 10 µM location ssDNA oligomer primer 
(Table S1)
For the transcriptomics side of the chip, the separation valve was closed after bead collection 
and chip cleavage (Fig. S1b, valve 11). The microfluidic filter containing the beads was 
incubated in a reverse transcriptase solution by passing the solution slowly through the filter 
and incubating at room temperature for 30 minutes, and at 42 °C for 90 minutes (Fig. S2c). 
Following reverse transcription, the beads and cDNA libraries were washed sequentially 
with TE-SDS, TE-TW, and 10 mM Tris pH 8.0. Beads were then incubated with 
exonuclease solution for 45 minutes at 37 °C. Following washes with TE-SDS, TE-TW, and 
water, the chip was cleaved into approximately a 5 mm x 10 mm piece without allowing the 
PDMS to separate from the glass.
Following the final chip cleavage, the remainder of the chip containing the microfluidic filter 
and beads was added to a 2 mL microcentrifuge tube and submerged in PCR solution. 
Manual PCR was performed by cycling the tube through the following steps: 1. Melt 2 
minutes @ 95 °C. 2. Chill 6 seconds in ice bath. 3. Anneal 2 minutes @ 64 °C. 4. Extend 5 
minutes @ 72 °C. After 7 cycles, the tube was incubated at 72 °C for 10 minutes and 5 µL of 
the sample was used for PCR. The manual PCR library was then frozen at −80 °C to 
preserve for any further sequencing. Library preparation and sequencing proceeded similarly 
to Dropseq analysis4. Following 17 cycles of PCR in 50 µL of PCR solution, DNA libraries 
were purified using Ampure XP beads and incubated with 5 µL Tagmentation solution and 
10 µL Tagmentation buffer for 5 minutes at 55 °C. The tagmented cDNA libraries were 
amplified using the Nextera PCR mix for 12 cycles using Nextera N70X indexing primers 
and P5-SMART primer (Table S1), and the amplified libraries were purified one final time. 
After Bioanalyzer and Qubit analysis, a 4 nM cDNA library was incubated with an equal 
volume of 0.2 M NaOH for five minutes to denature, and 10 µL of the denatured library was 
mixed with 990 µL HT1 buffer. 300 µL of the diluted library was mixed with 300 µL HT1 
buffer and added to the Miseq sequencing cartridge, and 4 µL of custom sequencing primer 
(Custom Read 1 Primer, Table S1) was added to well 12 of the Miseq cartridge. The cDNA 
library was sequenced on an Illumina MiSeq machine.
Data Analysis and Computation Pipeline.
Materials needed:  R script (File S2), Dropseq tools (http://mccarrolllab.com/dropseq/), 
STAR alignment (https://github.com/alexdobin/STAR).
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Following sequencing, transcripts were aligned and assigned to beads largely as suggested 
by the Dropseq tools available online. Instead of the typical Dropseq protocol used to correct 
errors in the bead identifier sequence, we developed an alternative method first to correct 
errors in the bead identifiers and then to determine the location of origin for each bead. We 
developed this method to perform the two bead clustering steps: the first by close 
mismatches in bead identifier sequences and UMIs, and the second by location, which 
required the formation of an external dictionary to group bead identifier sequences together. 
This method is detailed in the supplemental R code.
First, the most commonly appearing bead identifiers, either those that collectively account 
for 66% of the reads or those with more than 0.1% of the total reads sequenced each (Fig. 
2a), were extracted and clustered based on their DNA sequences (Fig. 2b). We used the 
Levenshtein distance metric, which allows substitutions, insertions, and deletions. Alike 
beads that clustered at Levenshtein distance of 1 or less were assigned a common bead 
identifier. The remainder of the reads with different bead identifiers were only assigned to 
one of these common bead identifiers if they were similar in sequence (Fig. 2c).
The location-encoding ssDNA sequences (Table S1) for each of the common bead identifiers 
were then extracted, checked for sequence similarity, and counted. If the most frequent X or 
Y ssDNA sequence of a bead identifier comprised more than 60% of the total X or Y ssDNA 
sequences associated with that bead identifier and at least 10 total location ssDNA sequences 
were extracted from that bead, then that common bead identifier was considered to have 
passed filter (Fig. 2d). All beads that passed filter were then grouped into a location-specific 
bead identifier which was used to collect the reads originating from every bead that shared a 
common location. The Dropseq pipeline was then applied to this final location-compressed 
sequencing data.
Single cell and single chamber transcript data was analyzed using the Seurat package26. 
Additional R code was written to process proteomics data, including background subtraction 
and normalization to single cell averaged protein measurements for multi-cell chambers. 
Pairwise gene-protein correlations were performed for every gene-protein pair for each data 
set, but few correlations were significant given the size of the data set associated with each 
chip. Transcript data sets for pairwise correlations were processed by choosing only those 
genes that appeared at least 5 times in at least 1 cell, appeared more than a total of 15 times 
across all cells on a chip, and had a variance of more than 2. For the aggregated chip data 
set, following log-normalization, scaling, and variable gene analysis using the default Seurat 
parameters, the 5 chip data sets and 2 resampling data sets were aggregated and variable 
genes were chosen by only those variable genes from individual data sets that appeared in 
each sample, except for one of the HEK data sets which was smaller than the others.
To obtain variable genes for bulk transcriptomic chip analysis, 5 transcriptomic data sets 
available from the Gene Expression Omnibus (GEO) were selected, GSE79133 (HEK 1), 
GSM2794663 (U87 1 replicate 1), GSM2794664 (U87 1 replicate 2), GSM2486332 (HEK 
2), GSE89164 (HEK 3), and GSM2333485 (U87 2). These were treated as single cells in 
Seurat, variable genes were extracted, and a separate Seurat analysis was performed using 
only these genes as measured in the multi-omic SCBC dataset. Further details are available 
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in the R code. Other average bulk transcriptome measurements were obtained from the 
Human Protein Atlas (www.proteinatlas.org)27.
Bulk Proteomics
To perform bulk proteomics, a DEAL array chip with PDMS wells was incubated with 
DNA-antibody conjugates for 1 hour at 42 °C. After washing the chip, one million cells of 
each type were lysed in the multi-omic SCBC lysis buffer or standard SCBC lysis buffer9, 11 
for 10 minutes on ice. The lysate was sonicated for 45 seconds, then centrifuged at 14000 rcf 
for 10 minutes, added to the bulk proteomics chip, and incubated for 1 hour. After 1 hour of 
incubation with detection antibodies at room temperature and 30 minutes washing in PBST, 
the PDMS wells were removed and the device was imaged.
Results and Discussion
Multi-Omic Chip Design and Operation
The multi-omic SCBC operating parameters were closely aligned to standard proteomic 
SCBC chips to maintain near-optimal proteomic measurements. This design choice was 
dictated by the difference between non-amplified protein signals and amplified transcript 
signals. However, certain steps were modified for multi-dimensional analysis. First, 
sequencing beads were 10, and not 30 microns in diameter. Standard Dropseq methods use 
larger beads4, but smaller beads allow smaller channels to be used, reducing bead settling 
and clogging issues and facilitating valve sealing. The use of location tagging also alleviates 
the loss of primers when using smaller beads by allowing multiple beads to be used in each 
chamber.
The cell lysis and capture step also required a compromise to balance the instability of 
transcripts and the kinetics of antibody binding of proteins, with protein capture typically 
requiring more time. The multi-omic SCBC used protein optimized lysis buffer with 
additional RNAse inhibitor, DTT, and low incubation temperatures to limit transcript 
degradation. Switching to the modified lysis buffer resulted in similar protein capture 
compared to the previously reported SCBC lysis buffer9. The modified buffer was important 
for generating high-quality transcriptome data compared to standard Dropseq buffer, 
considering the extended lysis time (Fig. S3). There are a variety of other lysis buffers 
available28 which may achieve similar results. Previous iterations of the protein-only SCBC 
also used a sonication step that was omitted to prevent shearing of transcripts and the 
displacement of beads into microfluidic dead space.
The next critical step was bead collection and chip splitting. The gold standards of 
measurement for different analytes are rarely complementary, thus requiring some degree of 
separation or splitting, in this case of proteins from transcripts. Previous multi-omic methods 
required this separation to occur on a cell-by-cell basis, which necessitated the use of either 
complex microfluidic mixers and valves22 or large dilutions of cellular contents to pipet-
friendly volumes20, placing a ceiling on throughput. By capturing a cell’s proteins on an 
antibody barcode at an X-Y location, and its transcripts on a bead labeled with X-Y location 
barcodes, we were able to split the contents of a chip collectively at a single step while 
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retaining the correlated measurements of each cell. Another compromise is made at this step, 
using 6X SSC instead of the typical PBST9 to collect beads and wash unbound analytes 
from cell chambers.
Separating proteins from transcripts is a crucial step which allows reverse transcription of 
bound transcripts to proceed at recommended temperatures without destabilizing protein-
antibody interactions. Here we chose to intervene at the macro level to split the chip directly, 
as opposed to collecting the beads through a fluidic outlet and performing PCR off-chip19. 
This is necessary for analyzing smaller numbers of cells where each cell and bead is 
essential to the analysis, and allows us to perform micro-scale enzymatic reactions and avoid 
the loss of beads during transfer off of the chip.
A significant amount of error correction and filtering was applied in digital space. The most 
common errors observed were single base pair deletions in bead identifiers and high 
variability in the 12th base pair of the bead identifier. Due to our unorthodox on-chip cDNA 
generation and manual PCR procedures, we anticipate that insertions and deletions occur 
more frequently, making Levenshtein distance a more appropriate metric than Hamming 
distance, which counts the distance between sequences by substitutions only. In our analysis 
of bead identifiers, we used 11 base pairs, which provides more than enough information 
diversity for the number of beads analyzed. In fact, the likelihood of duplicate or similar 
bead identifiers was very low given the small number of beads per chip (several hundred). 
We apply computationally intensive clustering to only 1–2% of bead identifiers and apply 
coarser clustering to the remainder of reads to collect all reads efficiently and quickly. After 
computational analysis, approximately half of the beads are discarded due to ambiguous 
location assignments.
Single Cell Isolation and Multi-Cell Chambers
We designed experiments to test whether the multi-omic SCBC could successfully capture 
both proteins and transcripts from single cells. The cell loading and isolation step effectively 
analyzes a bolus of injected cells, with the bolus size effectively limited by traditional tissue 
culture and cell purification methods. In principle, far fewer cells are needed as the 
microfluidic volume of the device is much less than 1 µL. However, we did not seek to 
optimize the device for highly efficient cell capture and loading. At this proof-of-concept 
phase, we generated a data set from 5 chips with 39 single cells, 102 total cell chambers and 
two cell types of different origins, HEK and U87, to provide contrast in transcriptomes. Each 
SCBC contained a DEAL barcode to assay for the levels of 3 proteins, pyruvate kinase 
isozyme M2 (PKM2), the c-Myc transcription factor, and pyruvate dehydrogenase kinase 
(PDHK) 1. These proteins are primarily localized to the cytosol, nucleus, and mitochondria 
respectively, allowing SCBC analysis to span the range of subcellular compartmentalization. 
While most microchambers contained 0 or 1 cell, a significant number contained 2 or more 
cells (Fig. 3a, Fig. S4a). The large ratio of beads to cells (4:1) loaded in the chip ensured that 
an excess of sequencing beads was available in each chamber.
We first ascertained that the recorded levels of proteins from a given microchamber 
correlated with the number of cells in that microchamber (Fig. 3b, Fig. S4b). Raw protein 
values are plotted, showing the background fluorescence and variance of zero-cell chambers. 
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For zero-cell chambers, the background fluorescence values exhibit no dependence on the 
number of neighboring cells, confirming that there is effective isolation between chambers 
for proteomic measurements (Fig. S4c). With large numbers of beads or cells, a stringing 
effect is observed as cellular material attaches to beads, making them difficult to collect and 
causing clogging, so we focus on microchambers containing 5 or fewer cells here to show 
the dose-dependence of analyte capture.
Transcript reads were first grouped by the bead identifier sequence specific to each bead. By 
then matching the bead identifier sequence of each bead with its sequenced X-Y coordinate 
oligos, we were able to link transcript reads from different beads to a shared microchamber 
(Fig. 3c). In Fig. 3d we present the numbers of reads per bead for microchambers with 
varying numbers of cells. Similar to the protein assays, we find a dose-dependence 
correlation up to about 3 cells per microchamber. There are also a small number of reads 
found on chambers with no cells, possibly captured during the bead pooling step. This 
demonstrates that both protein and transcriptome assays can be independently measured and 
traced back to the cell microchamber where those analytes were released.
Transcriptome Analysis
We then tested the quality of transcriptomic data captured from the SCBC as it related to 
other bead based methods4. We determined that for each chamber, the number of “digital” 
beads identified by sequencing bead identifiers was similar to the number of “physical” 
beads observed by microscope analysis (Fig. 4a). For each chamber with observed physical 
beads, digital beads were also identified, meaning no cell transcriptomes were lost. We 
observed that beads were lost more frequently when many beads were present, likely due to 
poor capture rates and clogging. Overall, 68% of physical beads were paired with digital 
sequencing data, with most unmatched digital beads being from chambers with >5 beads. 
Only 3.5% of beads were falsely tagged (e.g. 4 digital beads in a chamber with 3 physical 
beads), with 1% of digital beads being identified in chambers with no physical beads. These 
discrepancies can occur by poor bead collection, unequal distribution of transcripts across 
many beads within a chamber, transfer of barcodes between beads during bead collection, 
and PCR and synthesis errors.
After cDNA generation, the SCBC protocol diverges from typical Dropseq methods by the 
manual PCR step. We resampled manual PCR solutions to show that manual PCR-derived 
transcriptomes were reproducible (Fig. S4d). A general concern among all bead-based 
transcriptomics methods is the relatively low yield of transcripts per cell. We observed that 
the amount of reads per bead is insensitive to both the number of beads in a chamber and the 
number of cells above 1 (Fig. 4b). This suggests that each bead is saturated with transcripts 
below its theoretical capacity and most transcripts go uncaptured. Hierarchical clustering of 
the pooled RNA-seq data showed that transcriptome measurements were not clustered by 
their position on the chip, suggesting that there was little if any crossover between chambers 
(Fig. S4e).
Transcriptomes generated by the multi-omic SCBC averaged approximately 2000 unique 
genes and 6000 unique molecules for performance which, although not state-of-the-art for 
single cell RNA-seq5, is similar to reported Dropseq and related applications2, 29, 30, with 
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relatively high mitochondrial gene levels, likely due to the physical stresses of cell handling 
during the chip operation (Fig. 4c). Increased mitochondrial gene levels may also be a 
product of the long lysis times, which allows cytosolic transcripts to degrade and creates a 
delayed release effect for mitochondrial transcripts. The lysis times are a consequence of the 
manual operation of the microchip, and could be reduced via automating certain steps.
Cell Type Specific Signatures
We then tested the platform to determine whether it could resolve the unique biology 
associated with different cell types. Each cell type measured had a unique protein signature, 
with higher expression of c-MYC in HEK cells (Fig. 5a). The same relative protein signature 
is reproduced in bulk proteomic measurements (Fig. S5a). Some variation is seen between 
same-cell-type chips due to the small number of cells per chip (Fig. S5b).
To determine cell type-specific transcriptome signatures, we used public bulk transcriptomic 
data sets (3 HEK, 2 U87) to select 247 variable genes. We then carried out dimensional 
reduction of SCBC transcriptomes using these variable genes and we found that the HEK 
and U87 cells were easily distinguished (Fig. 5b). The coefficient of variation between chips 
within one cell type is substantially lower than the coefficient of variation between all chips, 
demonstrating that cell-type specific transcriptome variation is dominant over any batch 
effects between chips (Fig. S5c–e). Focusing on the subset of chambers containing only 
single cells, we observe that the cells continue to cluster by cell type with minimal batch 
effects despite the limited size of the data set (Fig. S5f, g). Using the full transcriptomic 
gene set, cell-type-specific transcriptome signatures were still present with 148 highly 
variable genes (Fig. S6a). Additional clustering effects such as mitochondrial gene levels 
were more readily observed (Fig. S6b).
The measurements of the 3 proteins and their corresponding transcripts were uncorrelated 
between single cells, but reflected bulk level trends. Public databases show that PKM2 
transcripts are expressed at the highest level (HEK: 1104.7 transcripts per million (TPM), 
U87: 3637.6 TPM), followed by c-MYC (HEK: 175.7 TPM, U87: 59.3 TPM) and PDHK1 
(HEK: 10.6 TPM, U87: 70.9 TPM)27, and these relative c-MYC and PDHK1 cell type-
specific abundances were reflected in bulk protein data (Fig. S5a). In accordance with these 
values, we detected PKM2 transcripts at approximately 6 counts per cell (HEK: 298.4 TPM, 
U87: 1209.5 TPM) and c-MYC at ~0.3 counts per cell (HEK: 0 TPM, U87: 30.9 TPM). 
Note that for rare transcripts such as PDHK1, which we did not detect in single cell 
transcriptomes, we were still able to obtain PDHK1 protein measurements. Increasing both 
the cell count and the numbers of proteins assayed would likely be necessary to reveal 
significant protein-transcript correlations, and accompanying biological insight (Fig. S6c).
Conclusions
Using the multi-omic SCBC, we demonstrated that single cell proteomic and transcriptomic 
data sets can be captured in their native measurement medium, using fluorescent sandwich 
immunoassays for proteins8, 9 and bead based sequencing for transcripts4, 5. These assays 
could be traced back to a particular location that contained a single microscopically imaged 
cell, or a defined small colony of cells. Compared to methods that convert mRNA to protein 
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signals or vice versa, our method has certain advantages. First, there is no clear limitation on 
the types of proteins that are assayed, and post-translational modification detection11 and 
certain metabolite assays9 should also be possible. Second, the mRNA measurements are not 
limited by the multiplex ceiling of proteins13, 14, 16. Further, proteins measured as DNA 
barcodes do not overwhelm the lower abundance transcript measurements17, 18. On the 
multi-omic SCBC, both measurements were obtained in a “one-pot” measurement step 
without requiring any manipulation of sub-cellular volumes.
However, there are a number of engineering challenges that need to be addressed to make 
the platform high-throughput and straightforward to operate. For example, two 
perpendicularly oriented flow patterning steps would permit X- and Y-location barcodes to 
be surface patterned, along with the antibody array for protein capture. Within a Cytoseq7 or 
Seq-well31 format of microwell arrays, such a design should permit a much higher number 
of cells to be analyzed at the proteomic and transcriptomic level, although new cell lysis 
chemistries would likely be required. We note that the original SCBC proteomics platform32 
required high operator skill and yielded relatively small numbers of analyzed cells with 
modest protein multiplexing capacity. This compares to the commercial hands-free SCBC 
platform in which the multiplexing capacity and the numbers of cells and distinct 
biospecimens analyzed are both dramatically increased. In the near term, the throughput of 
the modest sized SCBC used here should be increased through scaling the chip design, and 
further simplification of the workflow, perhaps by removing valve requirements, would 
improve the dissemination of SCBC methods. With a larger single cell data set, a myriad of 
bioinformatics tools becomes effective for further analysis including hierarchy inference33, 
multi-modal analysis26, and deeper phenotypic classification34–36.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Multi-omic SCBC schematic. a. The multi-omic SCBC combines the single cell proteomics 
SCBC with bead-based transcriptomics. The proteins are processed in the single cell 
microchambers, while sequencing beads are isolated for cDNA library generation before 
sequencing. b. Each microchamber in the SCBC contains (i.) an antibody barcode DEAL 
array, (ii.) sequencing beads, (iii.) cells, (iv.) X-coordinate ssDNA bound to the DEAL array, 
(v.) Y-coordinate ssDNA, and (vi.) DNA displacement oligos. c. Cell contents were released 
and location oligomers were introduced by opening a lysis valve. Note that the X-coordinate 
oligomer is released using a displacement strategy. d. After incubation, proteins were 
captured on the antibody DEAL array, and transcripts and location oligomers were captured 
on the sequencing beads. e. For these 6×6 chips, chambers were identified by their spatial 
coordinates on chip, and sequencing reads were sorted by their bead identifier sequence 
(red). These reads consisted of genes (blue), Y-coordinates (yellow), and X-coordinates 
(green), thus linking each bead identifier sequence to an X-Y location on chip. A spatial map 
of transcriptomes was generated and linked to proteomic measurements from each chamber.
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Figure 2. 
Digital bead identifier processing. a. Each bead identifier sequence (BI) is sorted by the 
frequency of its associated unique molecular identifiers (UMIs). b. A small fraction of BIs 
(~1–2%) contain approximately two-thirds of all UMIs, and these top BIs are clustered by 
their Levenshtein distance. c. Sequences with Levenshtein distance of 1 or less are grouped 
together as single beads and their UMIs pooled together. The remainder of the BIs are then 
grouped together with a top BI at Levenshtein distance 2 or less or discarded. d. Each of the 
grouped BIs and their pooled UMIs are analyzed for location barcode sequences. Beads that 
cannot be unambiguously assigned to a location are discarded to generate the complete 
digital location map of sequenced beads.
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Figure 3. 
Proteomic and transcriptomic quality metrics. a. Microchambers were stochastically loaded 
with cells and beads. The density was such that some chambers had no cells, but nearly 
every chamber had beads. b. Raw protein measurements from a chip show that adding cells 
increases the protein levels proportionally. Zero-cell chambers represented a clear 
background. c. Transcriptome measurements were clustered by bead and then by X-Y 
coordinates. This allowed reads from multiple beads in a chamber to be condensed to give a 
single chamber transcriptome. d. A plot of reads per bead versus the number of cells in the 
chamber shows that numbers of reads increases with numbers of cells, up to a few cells, 
after which the trend flattens.
Xu et al. Page 18
Lab Chip. Author manuscript; available in PMC 2019 October 23.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 4. 
Bead extraction by sequencing. a. Beads observed by microscope analysis are compared to 
the digital location map of sequenced beads for one chip (left) and all chips (right). For 
many chambers, the number of physical beads matches the number of digital beads assigned 
to that chamber’s location (diagonal line). In some multi-bead chambers, the number of 
digital sequenced beads is fewer than physical beads, especially as the bead count increases. 
Rarely are there more digital beads than physical beads, and every chamber with physical 
beads has at least one digital bead. b. The number of sequencing reads per bead is relatively 
insensitive to the number of beads in the chamber and the number of cells in the chamber 
above one. This suggests that there was an excess of transcripts, and that each bead is bound 
to near-capacity. Some sequencing background was found on all beads. c. U87 cells were 
sequenced at more depth than HEK cells for genes (U87: mean 2332, CV 52%; HEK: mean 
1710, CV 69%;) and UMIs (U87: mean 6729, CV 76%; HEK: mean 4326, CV 96%) 
detected per cell. Mitochondrial genes were detected at high proportions on SCBC chips 
(U87: mean 12.8%, CV 48%; HEK: mean 14.5%, CV 52%). Overall, sequencing metrics for 
the multi-omic SCBC are similar to other high throughput single cell sequencing methods, 
with higher mitochondrial gene counts.
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Figure 5. 
Cell type identification with the multi-omic SCBC. a. The aggregated data gathered from 
chips analyzing HEK and U87 cells showed that each cell type has a specific protein 
signature (student’s t-test), with increased c-MYC protein signals from HEK cells. b. Using 
variable genes from public data sets of HEK and U87 cells, SCBC transcriptomes clustered 
by cell type (t-SNE).
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